Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Castasterone is a naturally occurring plant steroid hormone belonging to the brassinosteroid class. It serves as a metabolic precursor to epibrassinolide and is considered the active brassinosteroid in many plant species. In the context of human health research, castasterone has demonstrated significant pharmacological activity against small-cell lung cancer (SCLC) cells, including those with multi-drug resistance. It exhibits pro-apoptotic effects and has been shown to reverse resistance to conventional chemotherapeutic agents like etoposide and doxorubicin. Its mechanism of action appears to involve the modulation of the Wnt signaling pathway, specifically through the reduction of the transcriptional activator beta-catenin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on castasterone.